AIM · AIM ImmunoTech Inc.
$0.26
+0.01 (+2.09%)
At close · Aug 21
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred losses from operations and operating cash outflows exceeded cash inflows from operating activities for the six months ended June 30, 2026. These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of at least one year from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 7, 2026
Market Cap
$7.70M
Shares
30.44M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding AIM
2 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | — | 27,999 | $11,418 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 682 | $278 | 0.00% | Long | 2026-05-31 |
Showing 1–2 of 2 positions
Key facts
CIK
946644
CUSIP
00901B303
13F (30d)
18 filings
18 filers
Visit website
Investor relations